Research Paper Volume 14, Issue 4 pp 1959—1982

Comparison of one-week versus three-week paclitaxel for advanced pan-carcinomas: systematic review and meta-analysis


Figure 7. The forest plot of OR for hematologic toxicities (anemia, leukopenia, thrombocytopenia, neutropenia, and febrile neutropenia) in the weekly paclitaxel compared to 3-weeks paclitaxel regimen. OR: odds ratio.